Canthal Lines Clinical Trial
Official title:
A Multi-center Randomized, Double-blind, Placebo Controlled, Parallel-group Study of CD07743 for the Improvement of Lateral Canthal Lines (Crow's Feet)
This double-blind study has two parts for each subject (same population):
Part A: initial treatment in Lateral Canthal Lines (LCL) (placebo-controlled):
- To assess the efficacy and safety of Azzalure® compared to placebo in the improvement of
moderate to severe LCLs.
- To assess the subjects' level of satisfaction with the appearance of their LCLs compared
to placebo.
Part B: repeated treatment in LCL with or without Glabellar Lines (GL) (active treatment, up
to 1 year):
- To assess safety of Azzalure® following repeated administration in the improvement of
moderate to severe LCLs.
- To assess the safety of Azzalure® when used concomitantly for improvement of moderate to
severe LCLs and GLs.
- To assess the subjects' level of satisfaction with the appearance of their LCLs.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05148000 -
Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
|
Phase 3 |